Tirzepatide injection for weight management

How Tirzepatide Injection works

Tirzepatide activates two receptors: GLP-1, which reduces appetite and slows stomach emptying, and GIP, another gut hormone involved in insulin release and energy balance. Acting on both appears to strengthen the effect on appetite and weight compared with GLP-1 action alone.

Who it’s for, and who it isn’t

What’s included

• Online assessment and visit with a licensed clinician
• Stepwise dose plan tailored to tolerance
• Medication shipped from a licensed U.S. pharmacy
• Follow-up check-ins and dose adjustments
• Advice on birth control, nutrition and muscle protection

Possible side effects

• Nausea, vomiting or diarrhea, most often during dose increases
• Constipation, indigestion and stomach pain
• Decreased appetite
• Injection-site reactions
• Less common but serious: pancreatitis, gallbladder disease, kidney injury from dehydration, allergic reactions, low blood sugar with insulin or sulfonylureas

This isn’t a complete list. Your clinician reviews risks, interactions and warnings with you before prescribing. In an emergency, call 911.

What the evidence says

Branded tirzepatide (Zepbound) was studied in a 72-week trial of adults with obesity or overweight without diabetes. Average weight change was about 15.0%, 19.5% and 20.9% on the 5, 10 and 15 mg doses, versus 3.1% on placebo. Those results come from the FDA-approved product; compounded tirzepatide has not been studied in those trials or reviewed by FDA.

How tirzepatide differs from semaglutide

Semaglutide acts on one receptor, GLP-1. Tirzepatide acts on GLP-1 and GIP, which is why it is often called a dual agonist. In the trials behind the branded products, tirzepatide produced larger average weight loss, but averages hide wide individual differences.

The better choice depends on your history, how you tolerate side effects, your budget and any medicines you already take. Some people do well on one and not the other. Your clinician can explain the trade-offs and help you switch if the first choice does not suit you.

Compounded, not branded

The tirzepatide prescribed through HealifyMD is compounded by a licensed U.S. pharmacy. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before use. They are not equivalent to Zepbound or Mounjaro and cannot be swapped for them.

Compounding is meant for situations where an approved product does not meet a patient's individual needs. Because doses are often measured from a vial, take time to learn how to read the syringe, and ask your clinician or pharmacist before every dose change if anything looks different.

The boxed warning and other cautions

Branded tirzepatide carries a boxed warning for thyroid C-cell tumors. In rats it caused these tumors in a dose-dependent way; whether it does in people is unknown. If you or a close relative has had medullary thyroid carcinoma, or you have MEN 2, tirzepatide is not an option.

The label also warns about pancreatitis, gallbladder problems such as gallstones, kidney injury when vomiting or diarrhea lead to dehydration, serious allergic reactions and low blood sugar when used with insulin or a sulfonylurea. Food can stay in the stomach longer, so tell any anesthesia team that you take it.

Who tends to be a good candidate

Branded tirzepatide is labeled for adults with obesity, or with overweight plus at least one weight-related condition, used alongside a reduced-calorie eating pattern and more activity. Your clinician uses that framework, then looks at the whole picture: your health history, current medications, blood pressure, any diabetes or prediabetes, sleep quality and what you have already tried.

Midlife changes often play a part. Shifts in estrogen or testosterone, poorer sleep and gradual muscle loss can all make weight harder to manage after 40. Medication can quiet the appetite side of the equation, but it works best when sleep, strength training and protein are part of the plan too. If something else is driving weight gain, such as an underactive thyroid or a medication side effect, your clinician may suggest addressing that first.

Birth control needs a plan

Tirzepatide slows stomach emptying, and the label says this may make birth control pills less effective. The usual advice is to switch to a non-oral method, or add a barrier method, for four weeks after starting and for four weeks after each dose increase. If you are perimenopausal and still could conceive, raise this at your first visit.

What your clinician watches

Your clinician starts low and increases the dose in steps, usually about a month apart, only if you are tolerating it. There is no prize for reaching the highest dose; the right dose is the lowest one that is working for you.

Follow-up covers your weight trend, appetite, digestive symptoms, hydration and blood pressure. If you have diabetes, glucose and your other medicines get close attention. Labs, billed separately, can check kidney function, glucose and lipids over time.

• Severe or ongoing stomach pain: stop and seek care
• Vomiting or diarrhea that keeps you from drinking: call your clinician
• Neck lump, hoarseness or trouble swallowing: report promptly
• Rash, facial swelling or trouble breathing: emergency care

Keeping the results

Like other drugs in this class, tirzepatide helps while you take it, and weight tends to return when it stops. Protein at each meal, regular resistance exercise and good sleep help protect muscle during weight loss and make the transition off medication easier if you choose to stop later.

Pricing starts at $399 a month, or $750 for two months ($375 a month), and new patients get $100 off the first month. There is no membership fee, labs are billed separately, and your price is confirmed at the eligibility review.

Go deeper on Tirzepatide Injection